Ocular Therapeutix
OCUL
#3717
Rank
โ‚น305.60 B
Marketcap
โ‚น1,434
Share price
-0.99%
Change (1 day)
80.82%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2025 (TTM): -โ‚น21.61 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are โ‚น55.78 Million. In 2024 the company made an earning of -โ‚น17.41 Billion a decrease over its 2023 earnings that were of -โ‚น7.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น21.61 Billion24.15%
2024 -โ‚น17.41 Billion139.68%
2023 -โ‚น7.27 Billion13.65%
2022 -โ‚น6.39 Billion984.05%
2021 -โ‚น0.59 Billion-95.79%
2020 -โ‚น14 Billion80.19%
2019 -โ‚น7.77 Billion44.01%
2018 -โ‚น5.4 Billion-5.38%
2017 -โ‚น5.71 Billion41.79%
2016 -โ‚น4.03 Billion12.47%
2015 -โ‚น3.58 Billion38.75%
2014 -โ‚น2.58 Billion115.12%
2013 -โ‚น1.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Intersect ENT
XENT
-โ‚น14.51 Billion-35.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
โ‚น1.17 B-105.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚น21.82 B-197.22%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
-โ‚น1.01 Billion-95.51%๐Ÿ‡บ๐Ÿ‡ธ USA